Hyperliquid Strategies (NASDAQ:PURR) Price Target Raised to $8.45

Hyperliquid Strategies (NASDAQ:PURR) had its price target increased by Chardan Capital from $8.15 to $8.45 in a research report released on Thursday,Benzinga reports. They currently have a buy rating on the stock.

Hyperliquid Strategies Price Performance

Shares of NASDAQ:PURR opened at $4.32 on Thursday. The stock has a market capitalization of $535.55 million, a PE ratio of -1.27 and a beta of 1.57. Hyperliquid Strategies has a one year low of $3.01 and a one year high of $5.78.

Hyperliquid Strategies (NASDAQ:PURR) last posted its quarterly earnings data on Wednesday, February 11th. The company reported ($7.43) EPS for the quarter. The business had revenue of $0.50 million during the quarter.

Hedge Funds Weigh In On Hyperliquid Strategies

Several institutional investors have recently bought and sold shares of PURR. GM Advisory Group LLC purchased a new stake in shares of Hyperliquid Strategies in the fourth quarter valued at about $2,946,000. HRT Financial LP acquired a new stake in Hyperliquid Strategies in the fourth quarter valued at about $856,000. Jane Street Group LLC purchased a new stake in Hyperliquid Strategies in the 4th quarter valued at approximately $339,000. Finally, EHP Funds Inc. purchased a new stake in Hyperliquid Strategies in the 4th quarter valued at approximately $302,000. 9.45% of the stock is owned by institutional investors and hedge funds.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.